Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04723303 · ClinicalTrials.gov registry record · Early Phase 1
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT04723303 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 10 participants.
The verdict
NCT04723303, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will investigate Umbilical Cord Lining Stem Cells (ULSC) as an investigational medicinal product and its use in patients with polymyositis (PM) or dermatomyositis (DM) to see if a single intravenous (IV) infusion of allogeneic umbilical cord lining stem cells (ULSC) safe, tolerable, and feasible to administer.
Interventions
- DRUG Umbilical Cord Lining Stem Cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2024-03-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04723303
The ClinicalTrials.gov registry entry for NCT04723303 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Umbilical Cord Lining Stem Cells is the first listed.
NCT04723303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04723303 about?
NCT04723303 is a clinical study titled "Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)". This study will investigate Umbilical Cord Lining Stem Cells (ULSC) as an investigational medicinal product and its use in patients with polymyositis (PM) or dermatomyositis (DM) to see if a single intravenous (IV) infusion of allogeneic umbilical cord lining stem cells (ULSC) safe, tolerable, and f...
What is the current status of trial NCT04723303?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2021-10-06. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT04723303?
The interventions under investigation include: Umbilical Cord Lining Stem Cells (DRUG).
Who is sponsoring clinical trial NCT04723303?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.